Literature DB >> 19011

Purification of rat liver particulate neutral ribonuclease and comparison of properties with pancreas and serum ribonucleases.

J Bartholeyns, P Baudhuin.   

Abstract

Rat liver particulate neutral ribonuclease (EC 3.1.4.22) was extensively purified (up to 40000-fold). It is shown to be an endonuclease, specific for pyrimidine bases, hydrolysing 5'-phosphate ester bonds. The enzyme specificity, Km, pH optimum, stability in acid medium and thermal stability at high temperature are the same as those of rat pancreatic and serum ribonucleases. Like pancreatic and serum neutral ribonucleases, the hepatic enzyme is sensitive to the liver natural inhibitor. This inhibitor was purified 8000-fold; its association with ribonuclease follows zero-order kinetics. These identical properties for ribonuclease of rat liver, pancreas and serum support the hypothesis [Bartholeyns, Peeters-Joris & Baudhuin (1975) Eur. J. Biochem. 60, 385-393] of an extrahepatic origin for the liver enzyme, the plasma ribonuclease of pancreatic origin being taken up by endocytosis in the liver. Neutral ribonuclease activity was detected in all rat organs investigated; its distribution among tissues is different from the distribution of the natural ribonuclear inhibitor.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 19011      PMCID: PMC1164846          DOI: 10.1042/bj1640675

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Hepatic nucleases. Extrahepatic origin and association of neutral liver ribonuclease with lysosomes.

Authors:  J Bartholeyns; C Peeters-Joris; P Baudhuin
Journal:  Eur J Biochem       Date:  1975-12-15

2.  Nature and possible origin of human serum ribonuclease.

Authors:  K K Reddi
Journal:  Biochem Biophys Res Commun       Date:  1975-11-03       Impact factor: 3.575

3.  Enteropancreatic circulation of digestive enzymes.

Authors:  C Leibow; S S Rothman
Journal:  Science       Date:  1975-08-08       Impact factor: 47.728

4.  Protein synthesis by rat intestinal mucosa. The role of ribonuclease.

Authors:  D H Alpers; K J Isselbacher
Journal:  J Biol Chem       Date:  1967-12-10       Impact factor: 5.157

5.  Ribonuclease. VI. Partial purification and characterization of the ribonucleases of rat liver mitochondria.

Authors:  J S ROTH
Journal:  J Biol Chem       Date:  1957-08       Impact factor: 5.157

6.  Ribonuclease. V. Studies on the properties and distribution of ribonuclease inhibitor in the rat.

Authors:  J S ROTH
Journal:  Biochim Biophys Acta       Date:  1956-07

7.  Protein chromatography on calcium phosphate columns.

Authors:  S HJERTEN; O LEVIN; A TISELIUS
Journal:  Arch Biochem Biophys       Date:  1956-11       Impact factor: 4.013

8.  Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue.

Authors:  C DE DUVE; B C PRESSMAN; R GIANETTO; R WATTIAUX; F APPELMANS
Journal:  Biochem J       Date:  1955-08       Impact factor: 3.857

9.  Ribonuclease. III. Ribonuclease activity in rat liver and kidney.

Authors:  J S ROTH
Journal:  J Biol Chem       Date:  1954-05       Impact factor: 5.157

10.  The tissue origins of serum and urinary alpha-amylase.

Authors:  R C Karn; R J Wise; A D Merritt
Journal:  Arch Biochem Biophys       Date:  1976-07       Impact factor: 4.013

View more
  3 in total

1.  Ribonuclease activities in rat sympathetic ganglia: evidence for the presence of an endogenous inhibitor of alkaline ribonuclease.

Authors:  D J Bates; R T Good; L Austin
Journal:  Neurochem Res       Date:  1985-05       Impact factor: 3.996

2.  Bleach gel: a simple agarose gel for analyzing RNA quality.

Authors:  Patrick S Aranda; Dollie M LaJoie; Cheryl L Jorcyk
Journal:  Electrophoresis       Date:  2012-01       Impact factor: 3.535

3.  The different intron 2 species excised in vivo from the E2A premRNA of adenovirus-2: an approach to analyse alternative splicing.

Authors:  P Keohavong; R Gattoni; P Schmitt; J Stévenin
Journal:  Nucleic Acids Res       Date:  1986-07-11       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.